These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 15479089)

  • 1. Crystal engineering approach to forming cocrystals of amine hydrochlorides with organic acids. Molecular complexes of fluoxetine hydrochloride with benzoic, succinic, and fumaric acids.
    Childs SL; Chyall LJ; Dunlap JT; Smolenskaya VN; Stahly BC; Stahly GP
    J Am Chem Soc; 2004 Oct; 126(41):13335-42. PubMed ID: 15479089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrochloride salt co-crystals: preparation, characterization and physicochemical studies.
    Parmar VK; Shah SA
    Pharm Dev Technol; 2013; 18(2):443-53. PubMed ID: 22686294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical stability enhancement of theophylline via cocrystallization.
    Trask AV; Motherwell WD; Jones W
    Int J Pharm; 2006 Aug; 320(1-2):114-23. PubMed ID: 16769188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.
    Remenar JF; Morissette SL; Peterson ML; Moulton B; MacPhee JM; Guzmán HR; Almarsson O
    J Am Chem Soc; 2003 Jul; 125(28):8456-7. PubMed ID: 12848550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The salt-cocrystal continuum: the influence of crystal structure on ionization state.
    Childs SL; Stahly GP; Park A
    Mol Pharm; 2007; 4(3):323-38. PubMed ID: 17461597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocrystal or salt: does it really matter?
    Aakeröy CB; Fasulo ME; Desper J
    Mol Pharm; 2007; 4(3):317-22. PubMed ID: 17497799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cocrystals of acyclovir with promising physicochemical properties.
    Sarkar A; Rohani S
    J Pharm Sci; 2015 Jan; 104(1):98-105. PubMed ID: 25407552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for cocrystallization tendency: the role of intermolecular interactions.
    He G; Jacob C; Guo L; Chow PS; Tan RB
    J Phys Chem B; 2008 Aug; 112(32):9890-5. PubMed ID: 18646803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal engineering of stable temozolomide cocrystals.
    Babu NJ; Sanphui P; Nangia A
    Chem Asian J; 2012 Oct; 7(10):2274-85. PubMed ID: 22615256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuning mechanical properties of pharmaceutical crystals with multicomponent crystals: voriconazole as a case study.
    Sanphui P; Mishra MK; Ramamurty U; Desiraju GR
    Mol Pharm; 2015 Mar; 12(3):889-97. PubMed ID: 25587626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salt and cocrystals of sildenafil with dicarboxylic acids: solubility and pharmacokinetic advantage of the glutarate salt.
    Sanphui P; Tothadi S; Ganguly S; Desiraju GR
    Mol Pharm; 2013 Dec; 10(12):4687-97. PubMed ID: 24168322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms by which moisture generates cocrystals.
    Jayasankar A; Good DJ; Rodríguez-Hornedo N
    Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isostructural materials achieved by using structurally equivalent donors and acceptors in halogen-bonded cocrystals.
    Cincić D; Friscić T; Jones W
    Chemistry; 2008; 14(2):747-53. PubMed ID: 17955560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advantages of cocrystallization in the field of solid-state pharmaceutical chemistry: L-Proline and MnCl(2).
    Tilborg A; Michaux C; Norberg B; Wouters J
    Eur J Med Chem; 2010 Aug; 45(8):3511-7. PubMed ID: 20493591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New multi-component solid forms of anti-cancer drug Erlotinib: role of auxiliary interactions in determining a preferred conformation.
    Sanphui P; Rajput L; Gopi SP; Desiraju GR
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2016 Jun; 72(Pt 3):291-300. PubMed ID: 27240760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.
    Ober CA; Gupta RB
    AAPS PharmSciTech; 2012 Dec; 13(4):1396-406. PubMed ID: 23054991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cocrystal nicotinamide-succinic acid (2/1).
    Thompson LJ; Voguri RS; Cowell A; Male L; Tremayne M
    Acta Crystallogr C; 2010 Aug; 66(Pt 8):o421-4. PubMed ID: 20679721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.
    Nijhawan M; Santhosh A; Babu PR; Subrahmanyam CV
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1163-72. PubMed ID: 23829186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Succinic, fumaric, adipic and oxalic acid cocrystals of promethazine hydrochloride.
    Borodi G; Turza A; Onija O; Bende A
    Acta Crystallogr C Struct Chem; 2019 Feb; 75(Pt 2):107-119. PubMed ID: 30720448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.